Mark Clements Honored Among Becker’s Healthcare 2026 Great Leaders
Glooko, a global leader in digital health solutions for diabetes management, has announced that its Chief Medical and Strategy Officer, Dr. Mark Clements, has been recognized on Becker’s Healthcare’s prestigious 2026 “Great Leaders in Healthcare” list. The recognition underscores Dr. Clements’ impactful leadership in advancing clinically grounded innovation and evidence-based care in the field of diabetes management.
This annual recognition by Becker’s Healthcare highlights influential leaders who are shaping the future of healthcare through innovation, clinical excellence, and transformative leadership. Dr. Clements’ inclusion reflects his unique ability to bridge the gap between clinical practice, scientific research, and digital health technology—an increasingly vital intersection in modern healthcare.
Driving Clinically Grounded Innovation
At Glooko, Dr. Clements plays a central role in guiding the company’s clinical vision and long-term strategy. His work ensures that technological innovation remains firmly rooted in scientific evidence and aligned with real-world clinical needs. By maintaining this balance, he has helped the organization deliver solutions that not only advance care delivery but also improve outcomes for individuals living with diabetes.
Glooko’s platform is designed to support healthcare providers and patients by integrating data from various diabetes devices, enabling more informed decision-making and better glycemic control. Under Dr. Clements’ leadership, the company has strengthened its commitment to clinical rigor, ensuring that its products are both scientifically validated and practically useful in diverse healthcare settings.
Translating Complexity into Impact
One of Dr. Clements’ most notable strengths lies in his ability to translate complex clinical and data science insights into clear, actionable strategies. This skill has been instrumental in aligning Glooko’s teams around a shared mission: improving the lives of people with diabetes through smarter, data-driven care.
Dr. Clements helps translate complex clinical and data science insights into clear direction for our teams and keeps our work focused on meaningful impact,” said Mike Alvarez, Chief Executive Officer of Glooko. “His leadership ensures that our innovations are not only technologically advanced but also clinically relevant and beneficial to providers, health systems, and patients.”
This ability to connect data science with clinical application has positioned Glooko as a trusted partner for healthcare providers seeking to navigate the complexities of diabetes management in an increasingly digital world.
Advancing Evidence-Based Care
Dr. Clements’ approach emphasizes evidence-driven decision-making, ensuring that every innovation is backed by robust clinical research. This commitment has helped Glooko build credibility within the healthcare community and foster strong collaborations with research institutions and clinical organizations.
By prioritizing evidence-based care, Dr. Clements has contributed to the development of solutions that enhance patient engagement, improve glycemic safety, and streamline workflows for healthcare professionals. His leadership has also supported the integration of real-world data into clinical practice, enabling more personalized and effective treatment strategies.
Bridging Research, Practice, and Technology
A defining aspect of Dr. Clements’ career is his ability to connect three critical domains: clinical practice, research, and digital innovation. This interdisciplinary approach is essential in addressing the complex challenges of diabetes management, which requires continuous monitoring, patient engagement, and adaptive treatment strategies.
Through his work at Glooko, Dr. Clements has helped create a model for how digital health companies can collaborate with clinicians and researchers to drive meaningful progress. His efforts have led to the development of tools that not only collect and analyze data but also provide actionable insights that can be directly applied in clinical settings.
Commitment to Improving Diabetes Care
Beyond his role at Glooko, Dr. Clements is widely recognized for his contributions to diabetes research and education. His work has been instrumental in advancing data-informed approaches to disease management, particularly for populations that face greater barriers to care, including youth and underserved communities.
His dedication to improving access to quality care and reducing disparities in diabetes outcomes reflects a broader commitment to healthcare equity. By leveraging technology and data, Dr. Clements has helped create solutions that are more inclusive and accessible, ensuring that a wider range of patients can benefit from advances in diabetes care.
Strengthening Glooko’s Clinical Leadership
Under Dr. Clements’ guidance, Glooko has enhanced its clinical strategy, expanded research collaborations, and refined its product development approach. These efforts have reinforced the company’s position as a leader in digital health and demonstrated the value of integrating clinical expertise into every stage of innovation.
The company’s focus on real-world care needs has been particularly impactful, enabling it to develop solutions that address the practical challenges faced by healthcare providers and patients alike. This approach has not only improved the effectiveness of Glooko’s offerings but also strengthened its relationships with healthcare organizations around the world.
Recognition by Becker’s Healthcare
Becker’s Healthcare’s “Great Leaders in Healthcare” list is a respected benchmark within the industry, celebrating individuals who are making significant contributions to the evolution of healthcare. The recognition of Dr. Clements highlights the importance of leadership that combines clinical insight, technological innovation, and a commitment to improving patient outcomes.
The list includes leaders from a wide range of sectors, including hospitals, health systems, digital health companies, and research institutions. Dr. Clements’ inclusion reflects the growing importance of digital health in shaping the future of care delivery.
Looking Ahead
As healthcare continues to evolve, the role of leaders like Dr. Clements will become increasingly critical. The integration of digital tools, data analytics, and clinical expertise is transforming how care is delivered, particularly in chronic disease management.
Glooko’s ongoing efforts to innovate in diabetes care, guided by Dr. Clements’ leadership, position the company to play a key role in this transformation. By continuing to prioritize evidence-based innovation and patient-centered solutions, Glooko aims to address the growing challenges of diabetes management and improve outcomes on a global scale.
Dr. Mark Clements’ recognition by Becker’s Healthcare is a testament to his exceptional leadership and his contributions to advancing diabetes care through clinically grounded innovation. His work at Glooko exemplifies the potential of combining clinical expertise with digital health technology to create meaningful improvements in patient care.
As the healthcare landscape continues to shift toward more data-driven and patient-centered approaches, leaders like Dr. Clements will remain at the forefront, shaping the future of medicine and improving the lives of millions of people living with diabetes.
About Glooko
Glooko is a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum. Glooko is uniquely positioned to be the enterprise partner of choice for healthcare providers seeking to reduce glycemic risk, improve safety, and support overburdened clinical teams with coordinated expertise across both outpatient and inpatient care settings.
